​

AVITA Medical (RCEL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RCEL Stock Forecast

AVITA Medical (RCEL) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $3.50, with a high of $3.50 and a low of $3.50. This represents a -23.41% decline from the last price of $4.57.

- $4 $8 $12 $16 $20 High: $3.5 Avg: $3.5 Low: $3.5 Last Closed Price: $4.57

RCEL Stock Rating

AVITA Medical stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (57.14%), 3 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 3 4 Strong Sell Sell Hold Buy Strong Buy

RCEL Price Target Upside V Benchmarks

TypeNameUpside
StockAVITA Medical-23.41%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks20.39%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$3.50$3.50$3.75
Last Closing Price$4.57$4.57$4.57
Upside/Downside-23.41%-23.41%-17.94%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26-321-6
Dec, 25-321-6
Nov, 25-312-6
Oct, 25-4-1-5
Sep, 25-4-1-5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 16, 2026Lake Street$3.50$3.60-2.78%-23.41%
Oct 17, 2025Frank TakkinenLake Street$4.00$5.38-25.65%-12.47%
Jan 08, 2025Brooks O'NeilLake Street$14.00$14.06-0.43%206.35%
May 14, 2024Matt O'BrienPiper Sandler$9.00$8.357.78%96.94%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 16, 2026Lake StreetHoldHoldhold
Nov 20, 2025BTIGSellNeutralupgrade
Oct 17, 2025Lake StreetBuyHolddowngrade
Aug 08, 2025BTIGBuySelldowngrade
Jan 08, 2025Lake StreetBuyBuyhold
Dec 24, 2024Cantor FitzgeraldOverweightOverweighthold
Aug 09, 2024Cowen & Co.BuyBuyhold
May 14, 2024Bank of America SecuritiesBuyBuyhold
May 14, 2024Piper SandlerNeutraldowngrade
Jun 27, 2023Cantor FitzgeraldOverweightinitialise

Financial Forecast

EPS Forecast

$-5 $0 $5 $10 $15 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$-1.57------
Avg Forecast$-2.77$-1.63$-2.48$-3.56$-1.12$1.43$9.11$16.90
High Forecast$-2.63$-1.57$-2.41$-3.20$-0.91$8.20$9.76$18.11
Low Forecast$-2.89$-1.80$-2.63$-3.77$-1.54$-0.97$8.72$16.17
Surprise %--3.68%------

Revenue Forecast

$0 $140M $280M $420M $560M $700M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$50.56M------
Avg Forecast$25.34M$34.18M$50.14M$66.51M$103.68M$158.35M$368.30M$627.30M
High Forecast$26.15M$36.94M$52.89M$70.16M$109.36M$162.11M$388.50M$661.70M
Low Forecast$24.32M$33.08M$48.47M$64.30M$100.23M$154.59M$356.05M$606.43M
Surprise %-47.91%------

Net Income Forecast

$-100M $20M $140M $260M $380M $500M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$-39.17M------
Avg Forecast$-69.33M$-47.03M$-35.38M$-87.06M$-30.66M$28.81M$230.96M$422.60M
High Forecast$-65.72M$-37.62M$-28.30M$-79.99M$-22.81M$205.06M$244.01M$452.72M
Low Forecast$-72.20M$-56.44M$-42.46M$-94.13M$-38.52M$-24.24M$217.92M$404.32M
Surprise %--16.72%------

RCEL Forecast FAQ

Is AVITA Medical stock a buy?

AVITA Medical stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AVITA Medical is a favorable investment for most analysts.

What is AVITA Medical's price target?

AVITA Medical's price target, set by 7 Wall Street analysts, averages $3.5 over the next 12 months. The price target range spans from $3.5 at the low end to $3.5 at the high end, suggesting a potential -23.41% change from the previous closing price of $4.57.

How does AVITA Medical stock forecast compare to its benchmarks?

AVITA Medical's stock forecast shows a -23.41% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (20.39%).

What is the breakdown of analyst ratings for AVITA Medical over the past three months?

  • January 2026: 0% Strong Buy, 50.00% Buy, 33.33% Hold, 16.67% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 50.00% Buy, 33.33% Hold, 16.67% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 50.00% Buy, 16.67% Hold, 33.33% Sell, 0% Strong Sell.

What is AVITA Medical’s EPS forecast?

AVITA Medical's average annual EPS forecast for its fiscal year ending in December 2023 is $-2.48, marking a 57.96% increase from the reported $-1.57 in 2022. Estimates for the following years are $-3.56 in 2024, $-1.12 in 2025, $1.43 in 2026, $9.11 in 2027, and $16.9 in 2028.

What is AVITA Medical’s revenue forecast?

AVITA Medical's average annual revenue forecast for its fiscal year ending in December 2023 is $50.14M, reflecting a -0.83% decrease from the reported $50.56M in 2022. The forecast for 2024 is $66.51M, followed by $103.68M for 2025, $158.35M for 2026, $368.3M for 2027, and $627.3M for 2028.

What is AVITA Medical’s net income forecast?

AVITA Medical's net income forecast for the fiscal year ending in December 2023 stands at $-35.381M, representing a -9.67% decrease from the reported $-39.168M in 2022. Projections indicate $-87.057M in 2024, $-30.663M in 2025, $28.81M in 2026, $230.96M in 2027, and $422.6M in 2028.